Concepedia

D. Cambridge

DC

15

Publications

971

Citations

13

H-Index

1977

Active since

Affiliations

Wellcome Trust(Current)

University College London

Pfizer (United Kingdom)

D. Cambridge is an author at Wellcome Trust specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyPhysiologyMolecular PharmacologyCardiovascular PharmacologyAnesthesiaHypertensionAnesthesiologyDrug Discovery

Publications per year

1977–2001

15

Publications

15

UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypes

D. Cambridge · European Journal of Pharmacology · 1981 · 289 citations

Molecular Pharmacology, Adrenal Gland, Functional Selectivity +9

Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

D. Cambridge, Davey Mj, R. Massingham · Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 1977 · 127 citations · Full text

Molecular Pharmacology, Medicine, Synaptic Transmission +6

THE PHARMACOLOGY OF ANTIHYPERTENSIVE DRUGS WITH SPECIAL REFERENCE TO VASODILATORS, α‐ADRENERGIC BLOCKING AGENTS AND PRAZOSIN

D. Cambridge, Michael Davey, R. Massingham · The Medical Journal of Australia · 1977 · 119 citations

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +17

Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse

Daryl D. Rees, Jayne Monkhouse, D. Cambridge et al. · British Journal of Pharmacology · 1998 · 86 citations · Full text

Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines

Graeme R. Martin, P. Leff, D. Cambridge et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1987 · 77 citations

5-Hydroxytryptamine Receptor, Functional Selectivity, Medicine +8

Rows per page

1–5 of 15